| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.001 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |